Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22277 | 24696459 | Diabetes Care | Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. | 2014 | Details |
| A22278 | 24695736 | J Biol Chem | Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice. | 2014 | Details |
| A22279 | 24694249 | Scand J Gastroenterol | Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease. | 2014 | Details |
| A22280 | 24693952 | BMC Res Notes | Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample. | 2014 | Details |
| A22281 | 24693306 | Hepat Mon | Diet macronutrients composition in nonalcoholic Fatty liver disease: a review on the related documents. | 2014 | Details |
| A22282 | 24692138 | Compr Physiol | Energy metabolism in the liver. | 2014 | Details |
| A22284 | 24691745 | Mol Biol Rep | Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries. | 2014 | Details |
| A22286 | 24689950 | Metab Syndr Relat Disord | The relation between carotid intima media thickness and serum osteoprotegerin levels in nonalcoholic fatty liver disease. | 2014 | Details |
| A22287 | 24689911 | Metab Syndr Relat Disord | Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease. | 2014 | Details |
| A22290 | 24689234 | Yao Xue Xue Bao | [Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-iR mice and its mechanism]. | 2013 | Details |
| A22291 | 24689101 | J Gastrointestin Liver Dis | Recreational drugs: a new health hazard for patients with concomitant chronic liver diseases. | 2014 | Details |
| A22292 | 24689094 | J Gastrointestin Liver Dis | Healthy PNPLA3 risk allele carriers present with unexpected body fat composition. A study of one thousand subjects. | 2014 | Details |
| A22293 | 24688399 | ScientificWorldJournal | Ameliorative potential of Tamarindus indica on high fat diet induced nonalcoholic fatty liver disease in rats. | 2014 | Details |
| A22294 | 24688217 | J Clin Biochem Nutr | Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice. | 2014 | Details |
| A22295 | 24685479 | Biochem Biophys Res Commun | Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis. | 2014 | Details |
| A22296 | 24685236 | J Acad Nutr Diet | Vegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth. | 2014 | Details |
| A22297 | 24684407 | Diabet Med | Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes. | 2014 | Details |
| A22298 | 24684403 | Liver Int | Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD. | 2014 | Details |
| A22299 | 24684289 | Liver Int | Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. | 2014 | Details |
| A22300 | 24683323 | ScientificWorldJournal | A novel role of globular adiponectin in treatment with HFD/STZ induced T2DM combined with NAFLD rats. | 2014 | Details |
| A22301 | 24680992 | J Ethnopharmacol | In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism. | 2014 | Details |
| A22302 | 24680680 | Biochem Biophys Res Commun | Adiponutrin: a multimeric plasma protein. | 2014 | Details |
| A22303 | 24679017 | Nutr Hosp | [Adiposity as a risk factor of non alcoholic fat disease; systematic review]. | 2014 | Details |
| A22304 | 26425524 | Endosc Ultrasound | Epicardial fat as the predictor for essential hypertension and early vascular damage in patients with metabolic syndrome and non-alcoholic fatty liver disease. | 2014 | Details |
| A22305 | 26202505 | Hepatol Int | Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease : HCC risk assessment by VTTQ. | 2014 | Details |
| A22306 | 24677740 | Pediatr Obes | Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery. | 2014 | Details |
| A22307 | 24677249 | Hepatology | Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. | 2014 | Details |
| A22308 | 24675715 | Int J Obes (Lond) | Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease. | 2014 | Details |
| A22309 | 24674765 | Liver Int | Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in rats. | 2014 | Details |
| A22310 | 24673432 | Expert Opin Pharmacother | Treatment options for managing atherogenic dyslipidemia and fatty liver disease. | 2014 | Details |
| A22311 | 24672641 | World J Hepatol | Thyroid hormone analogues and derivatives: Actions in fatty liver. | 2014 | Details |
| A22312 | 24672550 | Int J Cell Biol | An Intimate Relationship between ROS and Insulin Signalling: Implications for Antioxidant Treatment of Fatty Liver Disease. | 2014 | Details |
| A22313 | 24671009 | Curr Opin Gastroenterol | Current status of fibrosis markers. | 2014 | Details |
| A22314 | 24670599 | Hum Mol Genet | PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. | 2014 | Details |
| A22315 | 24669954 | Expert Opin Drug Metab Toxicol | Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. | 2014 | Details |
| A22316 | 24669786 | Diabetol Metab Syndr | Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals. | 2014 | Details |
| A22317 | 24668763 | Hepatology | Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. | 2014 | Details |
| A22318 | 24667697 | Clin Chim Acta | The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2014 | Details |
| A22319 | 24667593 | J Clin Gastroenterol | Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children. | 2015 | Details |
| A22320 | 24667349 | Eur J Gastroenterol Hepatol | Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22321 | 24665862 | Expert Rev Gastroenterol Hepatol | Management of fatty liver disease with the metabolic syndrome. | 2014 | Details |
| A22322 | 24665739 | Sheng Li Ke Xue Jin Zhan | [Progress in research of the mechanisms related with the hepatic steatosis in the nonalcoholic fatty liver disease]. | 2013 | Details |
| A22323 | 24661406 | Hepatol Res | Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges. | 2014 | Details |
| A22324 | 24660702 | AJR Am J Roentgenol | Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. | 2014 | Details |
| A22325 | 24660548 | Clin Lab | High-density lipoprotein size distribution can differ between subjects with alcoholic and non-alcoholic fatty liver disease. | 2014 | Details |
| A22326 | 24659891 | World J Gastroenterol | A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia. | 2014 | Details |
| A22327 | 24657938 | PLoS One | Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms. | 2014 | Details |
| A22328 | 24657400 | J Hepatol | Procoagulant imbalance in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22329 | 24656140 | Nutr Metab Cardiovasc Dis | Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. | 2014 | Details |
| A22330 | 24656139 | Nutr Metab Cardiovasc Dis | Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes. | 2014 | Details |
| A22331 | 24654688 | Clin Transplant | Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data. | 2014 | Details |
| A22332 | 24653792 | World J Hepatol | Fatty liver in childhood. | 2014 | Details |
| A22333 | 24653581 | Afr J Tradit Complement Altern Med | Schisandra chinensis Baill, a Chinese medicinal herb, alleviates high-fat-diet-inducing non-alcoholic steatohepatitis in rats. | 2013 | Details |
| A22334 | 24653580 | Afr J Tradit Complement Altern Med | p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats. | 2013 | Details |
| A22335 | 24652102 | J Gastroenterol | The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. | 2014 | Details |
| A22336 | 24652022 | Wien Klin Wochenschr | Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease. | 2014 | Details |
| A22337 | 24652019 | Wien Klin Wochenschr | Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients. | 2014 | Details |
| A22338 | 24651825 | J Antimicrob Chemother | Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A22339 | 24651520 | PLoS One | Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat). | 2014 | Details |
| A22340 | 24651470 | PLoS One | Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease. | 2014 | Details |
| A22341 | 24650811 | BMJ Open | Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. | 2014 | Details |
| A22342 | 24650559 | Am J Pathol | Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle. | 2014 | Details |
| A22343 | 24650018 | Liver Int | Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis. | 2014 | Details |
| A22344 | 24649929 | Liver Int | Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity. | 2014 | Details |
| A22345 | 24649902 | Liver Int | Genetic variations of superoxide dismutase 2 and cytochrome P450 2E1 in non-alcoholic steatohepatitis. | 2014 | Details |
| A22346 | 24649857 | Liver Int | Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD. | 2014 | Details |
| A22347 | 24648300 | J Clin Lab Anal | M30 does not predict the severity of hepatosteatosis, whereas adiponectin level declined with increase of ALT and the severity of hepatic steatosis. | 2014 | Details |
| A22348 | 24647824 | Eur Radiol | Application of localized ³¹P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22349 | 24647335 | J Pediatr Gastroenterol Nutr | Role of vitamin D in children with hepatosteatosis. | 2014 | Details |
| A22350 | 24646400 | Scand J Gastroenterol | Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first? | 2014 | Details |
| A22351 | 24645315 | Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi | [Model building-up and observation on the mouse carried chronic hepatitis B and nonalcoholic fatty liver disease]. | 2013 | Details |
| A22352 | 24645314 | Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi | [Protective effects of rhein on hepatic progression in HBV-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat diet]. | 2013 | Details |
| A22353 | 24645313 | Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi | [Activation of Kupffer cell and related signal pathway proteins in the liver of high fat and high fructose diet induced NAFLD mice]. | 2013 | Details |
| A22355 | 24642579 | Am J Gastroenterol | Risk factors for fatty liver in the Multicenter AIDS Cohort Study. | 2014 | Details |
| A22356 | 24641921 | Endocr Pract | Practice Patterns in Screening for Metabolic Disease in Women with PCOS of Diverse Race-Ethnic Backgrounds. | 2014 | Details |
| A22357 | 24639812 | Iran J Reprod Med | The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS. | 2013 | Details |
| A22358 | 24639417 | Diabetes Metab Res Rev | Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study. | 2014 | Details |
| A22359 | 24638096 | PLoS One | Evaluation of dietary effects on hepatic lipids in high fat and placebo diet fed rats by in vivo MRS and LC-MS techniques. | 2014 | Details |
| A22360 | 24638078 | PLoS One | Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. | 2014 | Details |
| A22361 | 24637730 | J Clin Gastroenterol | Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease. | 2015 | Details |
| A22362 | 24637477 | PLoS One | Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. | 2014 | Details |
| A22363 | 24637308 | J Clin Res Pediatr Endocrinol | Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. | 2014 | Details |
| A22364 | 24636073 | Hepatol Res | Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A22367 | 24634939 | Hepatogastroenterology | The roles of HBV infection and host factors in ultrasound-diagnosed fatty liver: a case-control study. | 2013 | Details |
| A22368 | 24634829 | Mol Metab | Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice. | 2014 | Details |
| A22369 | 24634500 | J Lipid Res | c9,t11-Conjugated linoleic acid ameliorates steatosis by modulating mitochondrial uncoupling and Nrf2 pathway. | 2014 | Details |
| A22370 | 24633463 | Arch Pharm Res | Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase. | 2014 | Details |
| A22371 | 24633023 | Intern Med | Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes. | 2014 | Details |
| A22372 | 24632889 | PLoS One | Association of liver enzymes and computed tomography markers of liver steatosis with familial longevity. | 2014 | Details |
| A22373 | 24632765 | Minerva Gastroenterol Dietol | Use of statins in patients with liver disease. | 2014 | Details |
| A22374 | 24632764 | Minerva Gastroenterol Dietol | Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease. | 2014 | Details |
| A22375 | 24631112 | J Acad Nutr Diet | A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls. | 2014 | Details |
| A22376 | 24631029 | Dig Liver Dis | Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. | 2014 | Details |
| A22377 | 24630507 | Arab J Gastroenterol | Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors? | 2014 | Details |
| A22378 | 24630506 | Arab J Gastroenterol | Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis. | 2014 | Details |
| A22379 | 24630174 | Cell Calcium | Calcium-dependent regulation of glucose homeostasis in the liver. | 2014 | Details |
| A22380 | 24629563 | Metabolism | Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. | 2014 | Details |
| A22381 | 24629059 | Obes Rev | Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis. | 2014 | Details |
| A22382 | 24628836 | Liver Int | n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. | 2014 | Details |
| A22383 | 24628717 | Hepatol Res | Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution. | 2014 | Details |